Cecile Rouleau Selected Research

Cecile Rouleau Research Topics

Disease

20	Neoplasms (Cancer) 01/2017 - 03/2004
5	Neuroblastoma 09/2015 - 02/2006
5	Carcinoma (Carcinomatosis) 10/2009 - 02/2006
4	Sarcoma (Soft Tissue Sarcoma) 09/2015 - 11/2008
4	Breast Neoplasms (Breast Cancer) 12/2011 - 11/2005
4	Multiple Myeloma 12/2011 - 02/2009
3	Melanoma (Melanoma, Malignant) 10/2011 - 04/2008
2	Carcinogenesis 01/2016 - 11/2008
2	Ewing Sarcoma (Sarcoma, Ewing) 09/2015 - 03/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2011 - 05/2006
2	Colonic Neoplasms (Colon Cancer) 05/2011 - 02/2006
2	Lymphoma (Lymphomas) 10/2009 - 05/2009
1	Ovarian Neoplasms (Ovarian Cancer) 09/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2011
1	Endometrial Neoplasms (Endometrial Cancer) 11/2011
1	Liver Neoplasms (Liver Cancer) 11/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2011
1	Hematologic Neoplasms (Hematological Malignancy) 05/2009
1	Leukemia 05/2009
1	Pathologic Processes 03/2009
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 02/2009
1	Liposarcoma 11/2008
1	Fibrosarcoma 11/2008
1	Osteosarcoma (Osteogenic Sarcoma) 11/2008
1	Synovial Sarcoma (Synovioma) 11/2008
1	Malignant Fibrous Histiocytoma 11/2008
1	Hepatocellular Carcinoma (Hepatoma) 02/2006
1	Neoplasm Metastasis (Metastasis) 02/2006
1	Glioma (Gliomas) 08/2004

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2011 - 08/2004
4	Membrane Proteins (Integral Membrane Proteins)IBA 09/2015 - 11/2008
4	Messenger RNA (mRNA)IBA 11/2011 - 03/2004
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 09/2015 - 05/2011
2	Immunoconjugates (Immunoconjugate)IBA 09/2015 - 09/2012
2	TubulinIBA 09/2012 - 10/2009
2	Angiogenesis InhibitorsIBA 11/2011 - 03/2011
2	Topotecan (Hycamtin)FDA LinkGeneric 05/2011 - 10/2008
2	topovaleIBA 05/2011 - 10/2008
2	Docetaxel (Taxotere)FDA Link 05/2011 - 10/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2011 - 10/2008
2	Topoisomerase I InhibitorsIBA 05/2011 - 10/2008
2	CamptothecinIBA 05/2011 - 10/2008
2	AntibodiesIBA 11/2008 - 05/2006
2	erucylphosphocholineIBA 08/2008 - 11/2005
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2016
1	4-azidobenzylcarazolol (pABC)IBA 09/2015
1	Trastuzumab (Herceptin)FDA Link 09/2012
1	E 10 (E-10)IBA 09/2012
1	dolastatin 15IBA 09/2012
1	erucylphospho- N,N,N- trimethylpropylammoniumIBA 12/2011
1	Formaldehyde (Formol)FDA Link 11/2011
1	ParaffinIBA 11/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2011
1	Genz-644282IBA 05/2011
1	Cytotoxins (Cytolysins)IBA 05/2011
1	Dacarbazine (DIC)FDA LinkGeneric 05/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2009
1	Vincristine (Oncovin)FDA LinkGeneric 10/2009
1	tasidotinIBA 10/2009
1	fludarabineIBA 05/2009
1	NucleosidesIBA 05/2009
1	Cladribine FDA LinkGeneric 05/2009
1	Clofarabine (Clolar)FDA Link 05/2009
1	Monoclonal AntibodiesIBA 03/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2009
1	OligonucleotidesIBA 02/2009
1	Melphalan (Alkeran)FDA LinkGeneric 02/2009
1	Thalidomide (Thalomid)FDA Link 02/2009
1	Antineoplastic Agents (Antineoplastics)IBA 02/2009
1	heparanaseIBA 02/2009
1	Bortezomib (Velcade)FDA Link 02/2009
1	CytokinesIBA 02/2009
1	defibrotideIBA 02/2009
1	NF-kappa B (NF-kB)IBA 02/2009
1	Immunotoxins (Immunotoxin)IBA 11/2008
1	AntigensIBA 04/2008
1	anthrax toxin (anthrax lethal factor)IBA 04/2008
1	Protein Tyrosine PhosphatasesIBA 02/2006
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2004

Therapy/Procedure

6	Therapeutics 11/2011 - 03/2004
1	Intravenous Administration 12/2011
1	Stem Cell Transplantation 02/2009